ESGAR 2019

A number of Australians and New Zealanders attended this years ESGAR meeting in Rome.  Current Chair Kirsten Gormly and executive member Jessica Yang hosted an ARGANZ at ESGAR dinner and spoke at the meeting.  It was wonderful to see so many 'locals' and gather ideas on ways ARGANZ may be able to connect with its members. Congratulations to Dr Edwin Ho from Sydney for his poster winning an ESGAR award. 2018 Mendelson Research Prize winner Dr Danielle Richmond from Melbourne enjoyed her free trip (click on the images to see full-sized images and slideshow)

New liver Medicare rebates in Australia

ARGANZ, acting on behalf of RANZCR, has been the lead applicant campaigning for a liver MRI rebate. After an extensive process this has now been approved for two patient populations. The first is patients with colorectal carcinoma and suspected liver metastases for the purpose of characterisation or interventional planning. The second patient population is patients with chronic liver disease (Childs-Pugh A&B) with known or suspected hepatocellular carcinoma and a liver lesion over 10mm. An additional item number has been created to co-claim hepatobiliary contrast agents, recognising that these are considerably more expensive for providers. The item numbers are likely to become active in May 2019.